Pressure BioSciences & The Alkaline Water Company
View On Demand

Taking The Mystery Out Of Cannabis And CBD

About the Event

CBD sales in the U.S. hit $4.6 billion in the U.S. in 2020. Yet, after decades of prohibition, there are many myths and mysteries surrounding CBD. Now with legalization happening in states across the country, it’s an industry in transition as new information, insights, and research data drive everything from processing and testing to how CBD is used to produce effective, desired results.

This Force panel discussion features:

  • Christopher Hudalla, PhD: Founder and CSO, ProVerde Labs who was named one of the top 10 influencers of cannabis science in the U.S.
  • Richard T. Schumacher: President and CEO of Pressure BioSciences, a company that will soon release its patented ultra-shear technology (UST) to improve the solubility and bioavailability of CBD oil, while also increasing shelf-life and dosing accuracy.
  • Richard “Ricky” Wright: Founder and CEO, of The Alkaline Water Company, which has launched CBD-infused bottled water to provide functional benefits to consumers. 

Join our panel discussion to learn how science is guiding the latest in CBD processing and research to improve safety and efficacy, and to accelerate consumer adoption.

View On-Demand Webinar


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.